As of January 2025, Suven Life Sciences has a market cap of $340.01M. This makes Suven Life Sciences the world's 13508th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $270.43M | 30.77% |
2023 | $206.79M | 17.97% |
2022 | $175.30M | -23.18% |
2021 | $228.18M | -1.60% |
2020 | $231.89M | -70.51% |
2019 | $786.46M | 35.56% |
2018 | $580.18M | 11.38% |
2017 | $520.89M | 17.64% |
2016 | $442.78M | -34.94% |
2015 | $680.57M | 26.16% |
2014 | $539.46M | 193.18% |
2013 | $184.00M | 132.52% |
2012 | $79.13M | 161.86% |
2011 | $30.22M | -52.99% |
2010 | $64.28M | -13.30% |
2009 | $74.14M | 79.26% |
2008 | $41.36M | -72.20% |
2007 | $148.79M | 585.55% |
2006 | $21.70M | 71.39% |
2005 | $12.66M | -18.63% |
2004 | $15.56M | -4.55% |
2003 | $16.31M | - |